alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsDiagonally Implicit Runge-Kutta Methods for Ordinary Differential Equations. A ReviewA review of diagonally implicit Runge-Kutta (DIRK) methods applied to rst-order ordinary di erential equations (ODEs) is undertaken. The goal of this review is to summarize the characteristics, assess the potential, and then design several nearly optimal, general purpose, DIRK-type methods. Over 20 important aspects of DIRKtype methods are reviewed. A design study is then conducted on DIRK-type methods having from two to seven implicit stages. From this, 15 schemes are selected for general purpose application. Testing of the 15 chosen methods is done on three singular perturbation problems. Based on the review of method characteristics, these methods focus on having a stage order of two, sti accuracy, L-stability, high quality embedded and dense-output methods, small magnitudes of the algebraic stability matrix eigenvalues, small values of aii, and small or vanishing values of the internal stability function for large eigenvalues of the Jacobian. Among the 15 new methods, ESDIRK4(3)6L[2]SA is recommended as a good default method for solving sti problems at moderate error tolerances.Document ID20160005923Acquisition SourceLangley Research CenterDocument TypeTechnical Memorandum (TM)AuthorsKennedy, Christopher A.Carpenter, Mark H.*(NASA Langley Research Center Hampton, VA, United States)*Date AcquiredMay 6, 2016Publication DateMarch 1, 2016Subject CategoryMathematical And Computer Sciences (General)Report/Patent NumberNF1676L-19716NASA/TM-2016-219173L-20597L-20470Funding Number(s)WBS: WBS 794072.02.07.02.01Distribution LimitsPublicCopyrightPublic Use Permitted.Available DownloadsNameType20160005923.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commodity Futures Trading Commission

# TIME AND DATE: 

9:00 a.m. EDT, Friday, September 29, 2023.

# PLACE: 

Virtual meeting.

# STATUS: 

Closed.

# MATTERS TO BE CONSIDERED: 

                        Enforcement matters. In the event that the time, date, or location of this meeting changes, an announcement of the change, along with the new time, date, and/or place of the meeting will be posted on the Commission's website at                         *https://www.cftc.gov/​.*

# CONTACT PERSON FOR MORE INFORMATION: 

Christopher Kirkpatrick, 202-418-5964.

*Authority:*5 U.S.C. 552b.                    

Dated: September 20, 2023.

Robert Sidman,

Deputy Secretary of the Commission.

[FR Doc. 2023-20706 Filed 9-20-23; 4:15 pm]

BILLING CODE 6351-01-P
Page | of 1

pow, 2 }
EGAL PROCE T1003 9 | -
PUBLICATION ra DIVISION h iz /k3 9/-10 SEP 0 2 2011

As of: September 02, 2011
Received: August 27, 2011
Status: Posted

PUBLIC SUBMISSION Posted: September 02, 2011

Tracking No. 80f066c5
‘Comments Due: September 30, 2011
Submission Type: Web

Docket: IRS-2010-0017
Requirement for Group Health Plans and Health Insurance Issuers to Provide Coverage of
Preventive Services under the PatientProtection and Affordable Care Act

Comment On: IRS-2010-0017-0038
Group Health Plans and Health Insurance Issuers Relating to Coverage of Preventive Services

under Patient Protection and Affordable Care Act: Amendment

Document: [RS-2010-0017-0145
Comment on FR Doc # 2011-19684

Galea 7 . .
Submitter Information

Address: 32669-4975
Submitter's Representative; NARAL Pro-Choice America

General Comment

I strongly support the new policy requiring health-insurance plans to cover birth control without a
copay, CMS-9992-IFC2. Thank you for this important improvement to women's health care.

I also want you to know that I am concerned that certain religious employers may be allowed to
opt out of the requirements. All women should have access to contraceptive coverage, regardless

of where they work.

This policy finally should make near-universal access to birth control
areality for all women who use it.

Improving women's access to birth control is positive in so many ways.
A woman who can plan when to have a family is able to participate in
society more fully. Allowing women to space their pregnancies
contributes to healthy childbearing. And ultimately, fewer unintended
pregnancies can reduce the need for abortion.

Thank you for following science-based recommendations and making
women's health a priority.

http://fdms.erulemaking net/fdms-web-agency/component/contentstreamer?objectld=09000... 9/2/2011
From: lejones50@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:00:17 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Lloyd Jones

Kailua, HI 96734
From: dgiesler@san.rr.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:29:23 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Joyce Giesler

San Diego, CA 92129
From: tktaylor@burns-wilcox.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:37:56 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Tina Taylor

Rhome, TX 76078
EXHIBIT 32 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350  In connection with the accompanying quarterly report on Form 10-K of Liverpool Group, Inc. for the period ending March 31, 2011, I, Daniel K. Leonard, President, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Chairman of the Board of Directors of Liverpool Group, Inc. hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:  1.Such annual report of Form 10-K for the period ending March 31, 2011, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and2.The information contained in such annual report of Form 10-K for the year ending March 31, 2011, fairly represents in all material respects, the financial condition and results of operations of Liverpool Group, Inc.  Date:  June 23, 2011LIVERPOOL GROUP, INC.By: /s/   Daniel K. LeonardDaniel K. Leonard
President, Chief Executive Officer, Chief Financial Officer,
Principal Accounting Officer and Chairman of the Board of Directors
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 15-60747

Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

CECIL PIERRE, also known as Cecile C. Pierre, Jr.,

Defendant-Appellant

Appeal from the United States District Court

for the Southern District of Mississippi

USDC No. 2:14-CR-2-1

Before KING, DENNIS, and COSTA, Circuit Judges.

PER CURIAM:*

Cecil Pierre appeals the sentence imposed following the revocation of his 

supervised release. Pierre argues that the district court’s decision to order the 

revocation sentences to run consecutively rather than concurrently resulted in 

a “substantively unreasonable” sentence.

Ordinarily, revocation sentences are reviewed under the “plainly 

unreasonable” standard. United States v. Miller, 634 F.3d 841, 843 (5th Cir. 

 

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not 

be published and is not precedent except under the limited circumstances set forth in 5TH 

CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

August 8, 2016

Lyle W. Cayce

Clerk

 Case: 15-60747 Document: 00513627248 Page: 1 Date Filed: 08/08/2016
No. 15-60747

2

2011). Although Pierre requested, prior to sentencing, that the district court 

run his revocation sentences concurrently, he did not object to the 

reasonableness of the consecutive sentence ultimately imposed. Because 

Pierre did not object to the substantive reasonableness of the sentence before 

the district court, his present challenge to his sentence is reviewed for plain 

error. See United States v. Whitelaw, 580 F.3d 256, 260 (5th Cir. 2009).

On revocation of supervised release, the district court may impose any 

sentence that falls within the statutory maximum term authorized. United 

States v. McKinney, 520 F.3d 425, 427 (5th Cir. 2008). While the 42-month 

total sentence exceeded the advisory range under the Sentencing Guidelines, 

it was within the statutory maximum. See 18 U.S.C. § 3583(e)(3). Revocation 

sentences exceeding the Guidelines range but not exceeding the statutory 

maximum have been upheld as a matter of routine against challenges that the 

sentences were substantively unreasonable. See Whitelaw, 580 F.3d at 265 

(affirming 36-month sentence where the advisory Guidelines range was 4-10 

months and citing similar cases). As the sentence did not exceed the statutory 

maximum, it did not constitute plain error. See id. 

The judgment of the district court is AFFIRMED.

 Case: 15-60747 Document: 00513627248 Page: 2 Date Filed: 08/08/2016
Exhibit
32.1


CERTIFICATION
OF CHIEF EXECUTIVE OFFICER


AND
CHIEF FINANCIAL OFFICER


PURSUANT
TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002




In
connection with the Annual Report of Nasus Consulting, Inc. (the “Company”) on
Form 10-K for the period ended December 31, 2008 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Russell R.
Desjourdy, Chief Executive Officer and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:




1.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and




2.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the
      Company.




Date:
April 8, 2008       
                                                       /s/ Russell R.
Desjourdy


Russell
R. Desjourdy


Chief
Executive Officer and


Chief
Financial Officer
Motion of 

BEFORE THE 

DEPARTMENT OF TRANSPORTATION 

WASHINGTON, D. C. 

11 ; j t I: I L~ 

AMERICAN AIRLINES, INC. DOT-OST-1996-1203 

for confidential treatment under Rule 

12 (Form 41, Schedule B-7) 

MOTION OF AMERICAN AIRLINES, INC. FOR 

CONFIDENTIAL TREATMENT UNDER RULE 12 

Communications with respect to this document should be sent to: 

VIRASB VAHIDI 

Senior Vice President -

Marketing and Planning 

and Chief Commercial Officer 

American Airlines, Inc. 

P.O. Box 619616, MD 5628 

DFW Airport, Texas 75261 

July 30, 2012 

WILLIAM K. RIS, JR. 

Senior Vice President -

Government Affairs 

American Airlines, Inc. 

1101 17th Street, N.W. 

Suite 600 

Washington, D.C. 20036 

FRANCIS C. HEIL 

Senior Attorney 

American Airlines, Inc. 

1101 17th Street, N.W. 

Suite 600 

Washington, D.C. 20036 

(202) 496-5642 

francis.heil@aa.com 
Motion of 

BEFORE TijE 

DEPARTMENT OF TRANSPORTATION 

WASHINGTON, D. C. 

AMERICAN AIRLINES, INC. 

for confidential treatment under Rule 

12 (Form 41, Schedule B-7) 

DOT-OST-1996-1203 

MOTION OF AMERICAN AIRLINES, INC. FOR 

CONFIDENTIAL TREATMENT UNDER RULE 12 

American Airlines, Inc., under 14 CFR 302.12, hereby 

moves that its Form 41, Schedule B-7 for 2Q2012 be accorded 

confidential treatment and withheld from public disclosure. 

The information for which confidential treatment is requested 

pertains to American's airframe and aircraft engine acquisitions and retirements. 

In accordance with the Department's Final Rule on Submitting Airline Data via the Internet, 75 Fed. Reg. 41580, 

41582, July 16, 2010, we are uploading our confidential report 

electronically to esubmit.rita.dot. 

On June 5, 1995, by letter of James W. Mitchell, Director, Office of Airline Statistics, the Department granted 

confidential treatment for a 10-year period to similar data 

filed by American. For the reasons stated in that letter, the 

current submission should also receive confidential treatment 

for 10 years. 
2 -

WHEREFORE, American moves that the schedule being 

submitted electronically to the above-referenced website be 

withheld from public disclosure under Rule 12 for a period of 

10 years. 

July 30, 2012 

Respectfully submitted, 

Francis C. Heil 

Senior Attorney 

American Airlines, Inc.
Exhibit 32.1



CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER AND PRINCIPAL ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002



I, James Edward Lynch, Jr., President and
Chief Executive Officer of FreeButton, Inc., hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:



| | 1. | the annual report on Form 10-K of FreeButton Inc. for the fiscal year ended December 31, 2013 (the
“Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | the information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of FreeButton, Inc.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------



|Dated: April 15, 2014 | FREEBUTTON, INC.                                                                                                                                                                        
|--------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|                      | By: /s/ James Edward Lynch, Jr.                                                                                                                                                         
|                      | James Edward Lynch, Jr.
        President, Chief Executive Officer and Secretary
        (Duly Authorized Officer, Principal Executive Officer and Principal
        Accounting Officer)
<TABLE> <S> <C>


<ARTICLE>                             5
<LEGEND>

This schedule  contains  summary  financial  information  extracted from Century
Properties  Fund XX 1999 Fourth  Quarter 10-KSB and is qualified in its entirety
by reference to such 10-KSB filing.

</LEGEND>

<CIK>                                 0000736909
<NAME>                                Century Properties Fund XX
<MULTIPLIER>                                  1,000


<S>                                     <C>
<PERIOD-TYPE>                         12-MOS
<FISCAL-YEAR-END>                     DEC-31-1999
<PERIOD-START>                        JAN-01-1999
<PERIOD-END>                          DEC-31-1999
<CASH>                                        1,718
<SECURITIES>                                      0
<RECEIVABLES>                                   678
<ALLOWANCES>                                      0
<INVENTORY>                                       0
<CURRENT-ASSETS>                                  0 <F1>
<PP&E>                                       32,141
<DEPRECIATION>                                    0
<TOTAL-ASSETS>                               36,807
<CURRENT-LIABILITIES>                             0 <F1>
<BONDS>                                      36,555
<PREFERRED-MANDATORY>                             0
<PREFERRED>                                       0
<COMMON>                                          0
<OTHER-SE>                                        0
<TOTAL-LIABILITY-AND-EQUITY>                 37,180
<SALES>                                           0
<TOTAL-REVENUES>                              8,954
<CGS>                                             0
<TOTAL-COSTS>                                     0
<OTHER-EXPENSES>                              9,885
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                            2,394
<INCOME-PRETAX>                                   0
<INCOME-TAX>                                      0
<INCOME-CONTINUING>                               0
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                                   (931)
<EPS-BASIC>                                  (19.14)<F2>
<EPS-DILUTED>                                     0
<FN>

<F1> Registrant has an unclassified balance sheet. <F2> Multiplier is 1.

</FN>


</TABLE>